Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in STEMI Patients Undergoing PCI (REVIVAL-3)
NCT00390832Phase 3Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Erythropoietin with Placebo (2 arms). Primary endpoint: Left ventricular ejection fraction. Started Dec 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00390832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390832.